So much new CLL material to read: Welcome to the... - CLL Support

CLL Support

22,532 members38,709 posts

So much new CLL material to read

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

Welcome to the Fourth 2019 Issue of The CLL Society Tribune! So much to read there including amazing patient stories and my wife's Cajun Gingerbread recipe: cllsociety.org/quarter-4-20...

More of my top 10 articles from ASCO:

#8 Surviving CLL is only part of the story if we are going to succumb to second cancers. This ASCO abstract studies second cancers in CLL patients on ibrutinib or acalabrutib. See: cllsociety.org/2019/12/asco...

In his #7 of the top 10 CLL abstracts from ASH, Dr. Koffman reviews the encouraging data on the benefits of transplants for Richter’s Transformations. See: cllsociety.org/2019/12/asco...

Guest writer, Brian Maxson is a CLL patient and an inquisitive engineer who lays out the points Dr. Stilgenbauer made at the ERIC meeting about the timely topic of sequential versus combination therapies in CLL. See:cllsociety.org/2019/11/asco...

Thanks.

Stay strong. We are all in this together

Brian Koffman

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
PlanetaryKim profile image
PlanetaryKim

Thank you for all this Brian!

sandpiper11 profile image
sandpiper11

Thank you Sir for all that you do.

You may also like...

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

acalabrutib....

Reading and Listening for Christmas Eve and the the 3rd night of Hanukkah

relapsed/refractory CLL. The link is:...

Dr. O'Brien on how she treats CLL frontline and Dr. Pagel on new ways to block BTK

option for her CLL patients....

Stopping ibrutinib and imaging in CLL

-in-cll-chronic-lymphocytic-leukemia/ Stay strong. We are all in this together. Brian Brian...

End of suspense! Here is Dr. Koffman's ASCO 2020 \"Top Pick\" #1!

untreated patients with chronic lymphocytic leukemia (CLL)....